How Do Newer Antidiabetic Drugs Lower Stroke Risk?
Studies suggest that lower stroke risk associated with newer antidiabetic therapies is not due to the drugs' tighter glycemic control. So, what is the mechanism?
Stay updated with breaking news from Larryb Goldstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Studies suggest that lower stroke risk associated with newer antidiabetic therapies is not due to the drugs' tighter glycemic control. So, what is the mechanism?
Patients treated with tenecteplase at up to 24 hours had a threefold higher rate of reperfusion without intracranial hemorrhage than those receiving best medical treatment.
The STOP-CAD study signaled a short course of an antithrombotic regimen might lower ischemic stroke risk in some patients without significantly increasing major bleeding.
TREND trial compares acute antiplatelet monotherapies
Trial from China shows potential of AI guidance for stroke care